TECH Stock Price, Chart, Stats & News

Bio-Techne Corporation
Save
TECH chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 65.22% |
Operating margin | 9.62% |
Pretax margin | 9.39% |
Net margin | 6.67% |
Effective tax rate | 28.97% |
ROA | 3.21% |
ROE | 4.10% |
D/E | 0.17x |
Interest coverage ratio | 12.59x |
TECH valuation
P/E | 79.44x |
P/S | 6.56x |
P/B | 3.95x |
P/CF | 31.85x |
P/FCF | 35.74x |
P/OCF | 31.85x |
PEG | 24.47x |
EV multiple | 34.30x |
About
Bio-Techne Corporation, headquartered in Minneapolis, Minnesota, is a global enterprise specializing in the development, production, and distribution of specialized life science tools, instrumentation, and support solutions for both research and clinical diagnostic markets. The company is organized into two key business units: Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment manufactures a broad array of biological components, including cytokines, growth factors, antibodies, small molecules, tissue culture sera, and cell selection technologies, which are instrumental across life science research, diagnostic applications, and advancements in cell and gene therapy.
Similar securities
Based on sector and market capitalization
Report issue











